Olink
Olink offers a high-multiplex technique to identify actionable biomarkers with a strong focus on the human plasma proteome. Their mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology.
Latest Content
Whitepaper
Advanced Immune Monitoring To Revolutionize Vaccine Development
This interview explores expert insights into cutting-edge methodologies that overcome these challenges, providing actionable insights to optimize vaccine safety and efficacy.
Product News
Thermo Fisher Scientific Completes Acquisition of Olink
Thermo Fisher Scientific Inc. has announced that it has completed its acquisition of Olink Holding AB, a provider of next-generation proteomics solutions.
eBook
Overcome the Challenges of Multiplex Immunoassays
This eBook delves into the significance of protein biomarkers and the advancements in immunoassay techniques, from traditional ELISA to cutting-edge multiplex immunoassays.
Webinar
Population-Level Multiomics for Precision Medicine
On-Demand
Our expert speaker will explore how the findings uncover previously unknown insights into disease biology that can help accelerate the identification of new therapeutic targets and biomarkers.
Product News
New State-of-the-Art Genomic Services Facility Opening in the UK
Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to open in early 2024.
Whitepaper
Detect Low Abundance Biomarkers in Murine Models
In this interview, delve into the significance of measuring immune mediators with high sensitivity, revolutionizing our understanding of disease dynamics.
Webinar
Advancing Biomarker Discovery in Ovarian Cancer With High-Throughput Proteomics
On-Demand
This webinar describes how a new platform for high-throughput proteomics was used to identify multiple proteins associated with ovarian cancer. A 22-protein model was derived that discriminates ovarian cancer cases from benign controls with high accuracy.
Product
Advertisement
PEA Technology
Proximity Extension Assay (PEA) technology is the unique technology behind our Olink® Explore platform and Olink® Target 96 and Target 48 panels.
Product
Advertisement
Olink® Signature Q100
Run Olink kits easy and convenient in your own lab with Olink® Signature Q100, a dedicated solution for qPCR readout of Olink panels. With seamless integration between panel analysis to data output, you can simplify your research process with Olink® Target, Olink® Flex and Olink® Focus protein biomarker panels.
Product
Advertisement
Olink® Flex
Olink® Flex is a customizable made-to-order product that enables the selection and combination of up to 21 human proteins into one biomarker panel. Mix and match from ~200 thoroughly pre-validated protein biomarkers.
Advertisement
